SNDL SNDL Inc.
Healthcare$1.44-0.69%ClosedMarket Cap: $373.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.48
P/S
0.55
EV/EBITDA
9.14
DCF Value
$-60.23
FCF Yield
10.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.2%
Operating Margin
-0.8%
Net Margin
-1.2%
ROE
-1.0%
ROA
-0.8%
ROIC
-0.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $195.9M | 27.0% | $-11.2M | $-9.9M | $— | — |
| Q4 null | $252.5M | 27.8% | $10.3M | $9.4M | $— | — |
| FY null | $946.4M | 27.3% | $-4.4M | $-15.8M | $— | — |
| Q3 null | $244.2M | 26.3% | $-9.4M | $-13.3M | $— | — |
| Q2 null | $244.8M | 27.6% | $2.9M | $2.9M | $— | — |
| Q1 null | $204.9M | 27.6% | $-8.2M | $-14.7M | $— | — |
| Q4 null | $257.7M | 26.7% | $-76.1M | $-67.1M | $— | — |
| FY null | $920.4M | 26.1% | $-103.8M | $-94.8M | $— | — |
| Q3 null | $236.9M | 26.6% | $-18.5M | $-19.3M | $— | — |
| Q2 null | $228.1M | 25.5% | $-4.8M | $-5.8M | $— | — |
| Q1 null | $197.8M | 25.5% | $-4.4M | $-2.6M | $— | — |
| Q4 2023 | $248.4M | 23.1% | $-84.9M | $-82.8M | $-0.31 | — |